Corrigendum: Phase I trial outcome of amnion cell therapy in patients with ischemic stroke (I-ACT)

Thanh G Phan^{1

2}, Rebecca Lim^{3

4}, Mirja Krause^{3

4}, Siow T Chan^{3

4}, Hannah McDonald^{3

4}, Poh-Yi Gan^{5

6}, Shenpeng R Zhang⁷, Liz J Barreto Arce⁷, Jason Vuong^{1

2}, Tharani Thirugnanachandran^{1

2}, Benjamin Clissold^{1

2}, John Ly^{1

2}, Shaloo Singhal^{1

2}, Marie Veronic Hervet^{1

2}, Hyun Ah Kim⁷, Grant R Drummond⁷, Euan M Wallace^{4

8}, Henry Ma^{1

2}, Christopher G Sobey⁷

Affiliations

¹ Clinical Trials, Imaging and Informatics Division, Stroke and Ageing Research, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
² Department of Neurology, Monash Health, Clayton, VIC, Australia.
³ The Ritchie Centre, Hudson Institute of Medical Research, Clayton, VIC, Australia.
⁴ Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia.
⁵ Department of Medicine, Centre for Inflammatory Diseases, Monash Medical Centre, School of Clinical Sciences, Monash University, Clayton, VIC, Australia.
⁶ Department of Immunology, Monash Health, Monash Medical Centre, Clayton, VIC, Australia.
⁷ Department of Microbiology, Anatomy, Physiology and Pharmacology, Centre for Cardiovascular Biology and Disease Research, School of Agriculture, Biomedicine and Environment, La Trobe University, Bundoora, VIC, Australia.
⁸ Victorian Department of Health, Melbourne, VIC, Australia.

Published Erratum

Thanh G Phan et al. Front Neurosci. 2023.

. 2023 Jul 31:17:1237920.

doi: 10.3389/fnins.2023.1237920. eCollection 2023.

¹ Clinical Trials, Imaging and Informatics Division, Stroke and Ageing Research, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
² Department of Neurology, Monash Health, Clayton, VIC, Australia.
³ The Ritchie Centre, Hudson Institute of Medical Research, Clayton, VIC, Australia.
⁴ Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia.
⁵ Department of Medicine, Centre for Inflammatory Diseases, Monash Medical Centre, School of Clinical Sciences, Monash University, Clayton, VIC, Australia.
⁶ Department of Immunology, Monash Health, Monash Medical Centre, Clayton, VIC, Australia.
⁷ Department of Microbiology, Anatomy, Physiology and Pharmacology, Centre for Cardiovascular Biology and Disease Research, School of Agriculture, Biomedicine and Environment, La Trobe University, Bundoora, VIC, Australia.
⁸ Victorian Department of Health, Melbourne, VIC, Australia.

Abstract

[This corrects the article DOI: 10.3389/fnins.2023.1153231.].

Keywords: allogeneic; clinical trial; ischemic stroke; phase I; stem cell.

Phase I trial outcome of amnion cell therapy in patients with ischemic stroke (I-ACT).
Phan TG, Lim R, Chan ST, McDonald H, Gan PY, Zhang SR, Barreto Arce LJ, Vuong J, Thirugnanachandran T, Clissold B, Ly J, Singhal S, Hervet MV, Kim HA, Drummond GR, Wallace EM, Ma H, Sobey CG. Phan TG, et al. Front Neurosci. 2023 May 9;17:1153231. doi: 10.3389/fnins.2023.1153231. eCollection 2023. Front Neurosci. 2023. PMID: 37229431 Free PMC article.